Columbia University Vagelos College of Physicians and Surgeons: New Innovator Award for a High-Risk, High-Reward Project
This year, Cancer researcher Neil Vasan, MD, PhD, was one of 58 investigators in the country to receive a prestigious New Innovator Award from the NIH’s High-Risk, High-Reward program, which supports unusually innovative research from early-career investigators. Vasan’s project will extend his work on the PI3K kinase to the entire “kinome,” all 556 kinase genes in the human genome. Kinases are one of the most important targets in precision oncology, but the ideal kinase targets or kinase drug combinations for most cancers have not been established. Learn more.